Clinical Trials Browser

INDUSTRY × Brain Neoplasms × Lomustine × Clear all

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT02986178 2025-07-11

Lerapolturev in Recurrent Malignant Glioma

Phase 2 Completed

121 enrolled 15 charts

CNS

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT04762069 2025-05-04

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Phase 2 Active not recruiting

210 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT02796261 2022-01-21

STELLAR

Phase 3 Unknown

343 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioma

NCT02765165 2021-07-23

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

26 enrolled 20 charts

CNS

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence

NCT02343406 2020-05-22

INTELLANCE-2

Phase 2 Completed

266 enrolled 23 charts

CNS

Brain Neoplasms, Glioblastoma

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Phase 2 Completed

141 enrolled

CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

NCT00503204 2009-11-25

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Phase 1 Completed

20 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasms

Clinical Trials

IPAX BrIGHT

Lerapolturev in Recurrent Malignant Glioma

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

STELLAR

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

INTELLANCE-2

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour